Cart 0

 

New PrecisA Monoclonals for cancer research

 

Jun 2023

Nowadays, several approaches aim to understand the biology of diseases by identifying promising markers, which may provide effective novel therapies.

The identification of molecular biomarkers is unquestionably essential and urgent for an accurate prognosis and the development of critical therapeutic targets in cancer research. Therefore, we must expand our knowledge as a step toward the design of practical and safe treatments. 

Atlas Antibodies released new PrecisA Monoclonals related to ovarian and glioma research.

 

Explore selected products

Needs

  • Specific and effective biomarkers able to identify early stages of the disease and reliable prognostic markers for predicting clinical responses as well as defining the divergent molecular pathways underlying the development of the disease.
  • Protein-related data such as citations, application-specific validation and sequence information, and homology, are paramount in the buying process and the single biggest driver for antibody choice.
  • A trusted source of data in order to feel confident in the purchase of new antibodies.

Why Atlas Antibodies?

  • Atlas Antibodies continues searching for better early detection markers and new therapeutic targets.
  • Over 12,000 product citations worldwide
  • Application-specific Enhanced Validation
  • Strong roots in the Human Protein Atlas
  • Transparency & open-access data

 

Ovarian markers - new monoclonals antibodies

Ovarian cancer is the deadliest form of female gynecologic cancers causing more deaths than any other cancer of the female reproductive system.

Read White Paper

Therefore, there is a high demand to identify biomarkers specific to this disease for screening for early detection, as well as new therapeutic targets. The capacity of these biomarkers to predict the existence, stages, and associated therapeutic efficacy of ovarian cancer would enable improvements in the early diagnosis and survival of ovarian cancer patients.

Discover new products:

 

Anti-MSH2 Antibody
Anti-MSH2 Antibody

Anti-MSH2 Antibody

AMAb91891
In Stock (10+)
3 490 kr
Anti-SMARCA4 Antibody
Anti-SMARCA4 Antibody

Anti-SMARCA4 Antibody

AMAb91895
In Stock (10+)
4 106 kr
Anti-BCOR Antibody
Anti-BCOR Antibody

Anti-BCOR Antibody

AMAb91902
In Stock (10+)
4 352 kr
Anti-MSH6 Antibody
Anti-MSH6 Antibody

Anti-MSH6 Antibody

AMAb91903
In Stock (10+)
4 106 kr
Anti-GREB1 Antibody
Anti-GREB1 Antibody

Anti-GREB1 Antibody

AMAb91905
In Stock (10+)
4 352 kr
Anti-MSH3 Antibody
Anti-MSH3 Antibody

Anti-MSH3 Antibody

AMAb91910
In Stock (10+)
4 106 kr
Anti-MSLN Antibody
Anti-MSLN Antibody

Anti-MSLN Antibody

AMAb91915
In Stock (10+)
4 106 kr
Anti-SMARCB1 Antibody
Anti-SMARCB1 Antibody

Anti-SMARCB1 Antibody

AMAb91919
In Stock (10+)
4 106 kr
Anti-MLH3 Antibody
Anti-MLH3 Antibody

Anti-MLH3 Antibody

AMAb91924
In Stock (10+)
4 352 kr
Anti-FXYD5 Antibody
Anti-FXYD5 Antibody

Anti-FXYD5 Antibody

AMAb91907
In Stock (10+)
4 352 kr
Anti-FXYD5 Antibody
Anti-FXYD5 Antibody

Anti-FXYD5 Antibody

AMAb91908
In Stock (10+)
4 352 kr

 

Glioma markers - new monoclonals antibodies

Gliomas are one of the most aggressive and lethal solid tumors of the central nervous system. Despite the alarming numbers, the molecular pathogenetic mechanisms of gliomas are not yet fully elucidated.

Understanding the dynamic glioma tumor microenvironment is necessary for the development of new immunotherapeutic strategies.

Gliomas are well-known tumors at the molecular level. However, these advances have not been translated into therapeutic benefits for the patients.

Discover new products:

 

Anti-IL33 Antibody
Anti-IL33 Antibody

Anti-IL33 Antibody

AMAb91858
In Stock (10+)
3 490 kr
Anti-ZEB2 Antibody
Anti-ZEB2 Antibody

Anti-ZEB2 Antibody

AMAb91862
In Stock (10+)
4 106 kr
Anti-PROX1 Antibody
Anti-PROX1 Antibody

Anti-PROX1 Antibody

AMAb91863
In Stock (10+)
4 106 kr
Anti-FOXO3 Antibody
Anti-FOXO3 Antibody

Anti-FOXO3 Antibody

AMAb91872
In Stock (10+)
3 490 kr
Anti-YAP1 Antibody
Anti-YAP1 Antibody

Anti-YAP1 Antibody

AMAb91878
In Stock (10+)
3 490 kr
Anti-WNT5A Antibody
Anti-WNT5A Antibody

Anti-WNT5A Antibody

AMAb91883
In Stock (10+)
4 106 kr
Anti-IGFBP2 Antibody
Anti-IGFBP2 Antibody

Anti-IGFBP2 Antibody

AMAb91884
In Stock (10+)
4 106 kr
Anti-LGR5 Antibody
Anti-LGR5 Antibody

Anti-LGR5 Antibody

AMAb91887
In Stock (10+)
4 106 kr
Anti-ADAM10 Antibody
Anti-ADAM10 Antibody

Anti-ADAM10 Antibody

AMAb91898
In Stock (10+)
4 106 kr